KDR and glioblastoma: Hamerlik et al. considered that directly inhibiting VEGFR2 kinases can block the highly dynamic VEGF-VEGFR2-Nrp1 pathway, thereby effectively inhibiting the development of GBM and improving the prognosis [37].